China Endocrine System Drug Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Endocrine System Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Eli Lilly

    • Merck

    • AbbVie

    • Sanofi

    • Novo Nordisk

    By Type:

    • Diabetes Drug

    • Thyroid Hormone Disorder Drugs

    • Others

    • Human Growth Hormones

    By Application:

    • Clinic

    • Hospital

    • Medical Center

    • Others

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Endocrine System Drug Market Overview 2018-2029

    • 1.1 China Endocrine System Drug Industry Development Overview

    • 1.2 China Endocrine System Drug Industry Development History

    • 1.3 China Endocrine System Drug Industry Market Size (2018-2029)

    • 1.4 China Endocrine System Drug Market Analysis by Type from Production Side

      • 1.4.1 China Endocrine System Drug Production Volume, Production Value and Growth Rate of Diabetes Drug (2018-2029)

      • 1.4.2 China Endocrine System Drug Production Volume, Production Value and Growth Rate of Thyroid Hormone Disorder Drugs (2018-2029)

      • 1.4.3 China Endocrine System Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.4 China Endocrine System Drug Production Volume, Production Value and Growth Rate of Human Growth Hormones (2018-2029)

    • 1.5 China Endocrine System Drug Market Analysis by Application from Consumption End

      • 1.5.1 China Endocrine System Drug Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

      • 1.5.2 China Endocrine System Drug Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

      • 1.5.3 China Endocrine System Drug Sales Volume, Sales Value and Growth Rate of Medical Center (2018-2029)

      • 1.5.4 China Endocrine System Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • 1.6 China Endocrine System Drug Market Analysis by Region

      • 1.6.1 North China Endocrine System Drug Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Endocrine System Drug Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Endocrine System Drug Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Endocrine System Drug Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Endocrine System Drug Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Endocrine System Drug Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Endocrine System Drug Market Size and Growth Rate from 2018-2029

    Chapter 2 China Endocrine System Drug Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Endocrine System Drug Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Endocrine System Drug Market Status and Competition Analysis in 2023

      • 2.2.3 China Endocrine System Drug Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Endocrine System Drug Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Endocrine System Drug Industry Development

    Chapter 3 Endocrine System DrugIndustry Chain Analysis

    • 3.1 Endocrine System Drug Industry Chain

    • 3.2 Endocrine System Drug Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Endocrine System Drug Market

    • 3.3 Endocrine System Drug Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Endocrine System Drug Market

    Chapter 4 China Endocrine System Drug Market, by Type

    • 4.1 China Endocrine System Drug Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Endocrine System Drug Total Production Volume and Growth Rate from Production Side

    • 4.5 China Endocrine System Drug Production Volume and Growth Rate, by Type

      • 4.5.1 China Endocrine System Drug Production Volume and Growth Rate of Diabetes Drug

      • 4.5.2 China Endocrine System Drug Production Volume and Growth Rate of Thyroid Hormone Disorder Drugs

      • 4.5.3 China Endocrine System Drug Production Volume and Growth Rate of Others

      • 4.5.4 China Endocrine System Drug Production Volume and Growth Rate of Human Growth Hormones

    Chapter 5 China Endocrine System Drug Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Endocrine System Drug Total Market Size and Growth Rate from Consumption End

    • 5.5 China Endocrine System Drug Market Size and Growth Rate, by Application

      • 5.5.1 China Endocrine System Drug Market Size and Growth Rate of Clinic

      • 5.5.2 China Endocrine System Drug Market Size and Growth Rate of Hospital

      • 5.5.3 China Endocrine System Drug Market Size and Growth Rate of Medical Center

      • 5.5.4 China Endocrine System Drug Market Size and Growth Rate of Others

    Chapter 6 China Endocrine System Drug Market, by Region

    • 6.1 China Endocrine System Drug Production Volume and Production Value, by Region

    • 6.2 China Endocrine System Drug Sales Volume and Sales Value, by Region

    Chapter 7 North China Endocrine System Drug Market Analysis

    • 7.1 North China Endocrine System Drug Market, by Type

    • 7.2 North China Endocrine System Drug Market, by Application

    Chapter 8 Central China Endocrine System Drug Market Analysis

    • 8.1 Central China Endocrine System Drug Market, by Type

    • 8.2 Central China Endocrine System Drug Market, by Application

    Chapter 9 South China Endocrine System Drug Market Analysis

    • 9.1 South China Endocrine System Drug Market, by Type

    • 9.2 South China Endocrine System Drug Market, by Application

    Chapter 10 East China Endocrine System Drug Market Analysis

    • 10.1 East China Endocrine System Drug Market, by Type

    • 10.2 East China Endocrine System Drug Market, by Application

    Chapter 11 Northeast China Endocrine System Drug Market Analysis

    • 11.1 Northeast China Endocrine System Drug Market, by Type

    • 11.2 Northeast China Endocrine System Drug Market, by Application

    Chapter 12 Southwest China Endocrine System Drug Market Analysis

    • 12.1 Southwest China Endocrine System Drug Market, by Type

    • 12.2 Southwest China Endocrine System Drug Market, by Application

    Chapter 13 Northwest China Endocrine System Drug Market Analysis

    • 13.1 Northwest China Endocrine System Drug Market, by Type

    • 13.2 Northwest China Endocrine System Drug Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Eli Lilly

        • 14.1.1 Eli Lilly Company Profile

        • 14.1.2 Eli Lilly Endocrine System Drug Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Merck

        • 14.2.1 Merck Company Profile

        • 14.2.2 Merck Endocrine System Drug Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 AbbVie

        • 14.3.1 AbbVie Company Profile

        • 14.3.2 AbbVie Endocrine System Drug Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Sanofi

        • 14.4.1 Sanofi Company Profile

        • 14.4.2 Sanofi Endocrine System Drug Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Novo Nordisk

        • 14.5.1 Novo Nordisk Company Profile

        • 14.5.2 Novo Nordisk Endocrine System Drug Market Performance

        • 14.5.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Endocrine System Drug Industry Research Conclusions

    • 15.2 Endocrine System Drug Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Endocrine System Drug Industry Market Size (2018-2029)

    • Figure China Endocrine System Drug Production Volume, Production Value and Growth Rate of Diabetes Drug (2018-2029)

    • Figure China Endocrine System Drug Production Volume, Production Value and Growth Rate of Thyroid Hormone Disorder Drugs (2018-2029)

    • Figure China Endocrine System Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Endocrine System Drug Production Volume, Production Value and Growth Rate of Human Growth Hormones (2018-2029)

    • Figure China Endocrine System Drug Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • Figure China Endocrine System Drug Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure China Endocrine System Drug Sales Volume, Sales Value and Growth Rate of Medical Center (2018-2029)

    • Figure China Endocrine System Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure North China Endocrine System Drug Market Size and Growth Rate from 2018-2029

    • Figure Central China Endocrine System Drug Market Size and Growth Rate from 2018-2029

    • Figure South China Endocrine System Drug Market Size and Growth Rate from 2018-2029

    • Figure East China Endocrine System Drug Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Endocrine System Drug Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Endocrine System Drug Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Endocrine System Drug Market Size and Growth Rate from 2018-2029

    • Figure Endocrine System Drug Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Endocrine System Drug Market Share by Type in 2018

    • Figure China Endocrine System Drug Market Share by Type in 2023

    • Figure China Endocrine System Drug Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Endocrine System Drug Production Volume and Growth Rate of Diabetes Drug (2018-2023)

    • Figure China Endocrine System Drug Production Volume and Growth Rate of Thyroid Hormone Disorder Drugs (2018-2023)

    • Figure China Endocrine System Drug Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Endocrine System Drug Production Volume and Growth Rate of Human Growth Hormones (2018-2023)

    • Figure China Endocrine System Drug Market Share by Application in 2018

    • Figure China Endocrine System Drug Market Share by Application in 2023

    • Figure China Endocrine System Drug Total Market Size and Growth Rate from Consumption End

    • Figure China Endocrine System Drug Market Size and Growth Rate of Clinic (2018-2023)

    • Figure China Endocrine System Drug Market Size and Growth Rate of Hospital (2018-2023)

    • Figure China Endocrine System Drug Market Size and Growth Rate of Medical Center (2018-2023)

    • Figure China Endocrine System Drug Market Size and Growth Rate of Others (2018-2023)

    • Table China Endocrine System Drug Production Volume by Region (2018-2023)

    • Table China Endocrine System Drug Production Volume Share by Region (2018-2023)

    • Figure China Endocrine System Drug Production Volume Share by Region (2018-2023)

    • Table China Endocrine System Drug Production Value by Region (2018-2023)

    • Table China Endocrine System Drug Production Value Share by Region (2018-2023)

    • Figure China Endocrine System Drug Production Value Share by Region (2018-2023)

    • Table China Endocrine System Drug Sales Volume by Region (2018-2023)

    • Table China Endocrine System Drug Sales Volume Share by Region (2018-2023)

    • Figure China Endocrine System Drug Sales Volume Share by Region (2018-2023)

    • Table China Endocrine System Drug Sales Value by Region (2018-2023)

    • Table China Endocrine System Drug Sales Value Share by Region (2018-2023)

    • Figure China Endocrine System Drug Sales Value Share by Region (2018-2023)

    • Table North China Endocrine System Drug Production Volume by Type (2018-2023)

    • Table North China Endocrine System Drug Production Volume Share by Type (2018-2023)

    • Figure North China Endocrine System Drug Production Volume Share by Type (2018-2023)

    • Table North China Endocrine System Drug Sales Volume by Application (2018-2023)

    • Table North China Endocrine System Drug Sales Volume Share by Application (2018-2023)

    • Figure North China Endocrine System Drug Sales Volume Share by Application (2018-2023)

    • Table Central China Endocrine System Drug Production Volume by Type (2018-2023)

    • Table Central China Endocrine System Drug Production Volume Share by Type (2018-2023)

    • Figure Central China Endocrine System Drug Production Volume Share by Type (2018-2023)

    • Table Central China Endocrine System Drug Sales Volume by Application (2018-2023)

    • Table Central China Endocrine System Drug Sales Volume Share by Application (2018-2023)

    • Figure Central China Endocrine System Drug Sales Volume Share by Application (2018-2023)

    • Table South China Endocrine System Drug Production Volume by Type (2018-2023)

    • Table South China Endocrine System Drug Production Volume Share by Type (2018-2023)

    • Figure South China Endocrine System Drug Production Volume Share by Type (2018-2023)

    • Table South China Endocrine System Drug Sales Volume by Application (2018-2023)

    • Table South China Endocrine System Drug Sales Volume Share by Application (2018-2023)

    • Figure South China Endocrine System Drug Sales Volume Share by Application (2018-2023)

    • Table East China Endocrine System Drug Production Volume by Type (2018-2023)

    • Table East China Endocrine System Drug Production Volume Share by Type (2018-2023)

    • Figure East China Endocrine System Drug Production Volume Share by Type (2018-2023)

    • Table East China Endocrine System Drug Sales Volume by Application (2018-2023)

    • Table East China Endocrine System Drug Sales Volume Share by Application (2018-2023)

    • Figure East China Endocrine System Drug Sales Volume Share by Application (2018-2023)

    • Table Northeast China Endocrine System Drug Production Volume by Type (2018-2023)

    • Table Northeast China Endocrine System Drug Production Volume Share by Type (2018-2023)

    • Figure Northeast China Endocrine System Drug Production Volume Share by Type (2018-2023)

    • Table Northeast China Endocrine System Drug Sales Volume by Application (2018-2023)

    • Table Northeast China Endocrine System Drug Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Endocrine System Drug Sales Volume Share by Application (2018-2023)

    • Table Southwest China Endocrine System Drug Production Volume by Type (2018-2023)

    • Table Southwest China Endocrine System Drug Production Volume Share by Type (2018-2023)

    • Figure Southwest China Endocrine System Drug Production Volume Share by Type (2018-2023)

    • Table Southwest China Endocrine System Drug Sales Volume by Application (2018-2023)

    • Table Southwest China Endocrine System Drug Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Endocrine System Drug Sales Volume Share by Application (2018-2023)

    • Table Northwest China Endocrine System Drug Production Volume by Type (2018-2023)

    • Table Northwest China Endocrine System Drug Production Volume Share by Type (2018-2023)

    • Figure Northwest China Endocrine System Drug Production Volume Share by Type (2018-2023)

    • Table Northwest China Endocrine System Drug Sales Volume by Application (2018-2023)

    • Table Northwest China Endocrine System Drug Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Endocrine System Drug Sales Volume Share by Application (2018-2023)

    • Table Eli Lilly Company Profile

    • Table Eli Lilly Endocrine System Drug Revenue, Price and Gross (2018-2023)

    • Table Merck Company Profile

    • Table Merck Endocrine System Drug Revenue, Price and Gross (2018-2023)

    • Table AbbVie Company Profile

    • Table AbbVie Endocrine System Drug Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Endocrine System Drug Revenue, Price and Gross (2018-2023)

    • Table Novo Nordisk Company Profile

    • Table Novo Nordisk Endocrine System Drug Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.